Toxicologists and scientists from related disciplines were invited to attend the SOT 59th Annual Meeting and ToxExpo in Anaheim, California. Although we were not able to participate in the conference, ATCC continues to pursue research and development in the area of toxicology. Feel free to view some of our content around toxicology and toxicity testing, including:
The Application of hTERT-immortalized Primary Cells in Toxicological Assays
Developing cell-based assays can be problematic; the cells must be physiologically relevant for the assay to be predictive, yet sufficiently abundant to be included in the assay without introducing interexperimental variability. hTERT-immortalized primary cells address both issues. hTERT-immortalized primary cells exhibit the growth characteristics of continuous cell lines while providing the physiological attributes of primary cells. In this presentation, ATCC experts will discuss the characteristics of hTERT-immortalized primary cells derived from the kidney, skin, airway, and vasculature and will describe the versatility of these cells in toxicological assays.
View the webinar on demand
Development of Assay-ready iPSCs-derived CD34+ Cells, Monocytes, and Mesenchymal Stem Cells
Presenter: Sheela Jacob, PhD, Scientist, ATCC
Poster Board Number: #P428
Permanent Abstract Number: 2091
View the Poster on Demand
An In Vitro Cell Model for Toxicity Studies and Pigmentation Regulation Utilizing hTERT-immortalized Neonatal Dermal Melanocytes
Presenter: Michelle Spencer, MS, Biologist, ATCC
Poster Board Number: #P785
Permanent Abstract Number: 2364
View the Poster on Demand
Toxicology Testing Products
Research takes time, don’t waste it by using poor quality materials
ATCC knows that worthwhile science takes time, especially in the toxicology, pre-clinical stages of drug development. It is critical that the standards and model organisms used in toxicological testing are reliable and authenticated. We can help streamline your research by providing the most authenticated, advanced, and functional models available. Let ATCC revolutionize and accelerate your toxicology studies in every phase of the research and testing process.
ATCC provides the cells, media, and reagents needed to explore each step of the in vitro preclinical testing process—from modeling, screening, and characterization to exploratory toxicology to pharmacokinetics and metabolism. We provide renal, neural, airway, and skin toxicity for such applications as high-content screening, 3D culture, spheroid culture, permeability assays, metabolic stability and survival studies, transport activity measurement, and more.
Where are you in your research?
Advanced models or tried and true cells – the choice is yours. Where are you in your research? Use the buttons below to find the model that most suits where you are in your toxicity testing.